Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen

BMC Women's Health

Volumn 9, Issue , 2009, Pages

  Lee, Sin Hang ^a   Vigliotti, Veronica S ^a   Pappu, Suri ^a  

^a Milford Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEINASE K; BACTERIAL DNA; E1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 31; VIRUS PROTEIN;

ADOLESCENT; ADULT; AMPLICON; ARTICLE; BINDING SITE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CYTOLOGY; DNA DETERMINATION; DNA SEQUENCE; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 6; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; NEISSERIA GONORRHOEAE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRECANCER; UTERINE CERVIX CANCER; WART VIRUS; CHLAMYDIASIS; CYTODIAGNOSIS; GENETICS; GONORRHEA; ISOLATION AND PURIFICATION; MICROBIOLOGY; SENSITIVITY AND SPECIFICITY; VIRUS INFECTION;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CYTODIAGNOSIS; DNA, BACTERIAL; FEMALE; GONORRHEA; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 16; HUMANS; NEISSERIA GONORRHOEAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS;

EID: 65449132393     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-9-8     Document Type: Article

References (43)

1. Manos MM Ting Y Wright DK Lewis AJ Broker TR Wolinsky SM Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses Cancer Cells 1989, 7:209-214.
2. Snijders PJ Brule van den AJ Schrijnemakers HF Snow G Meijer CJ Walboomers JM The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes J Gen Virol 1990, 71:173-181. 10.1099/ 0022-1317-71-1-173 2154534
3. Feoli-Fonseca JC Oligny LL Filion M Brochu P Simard P Russo PA Yotov WV A two-tier polymerase chain reaction direct sequencing method for detecting and typing human papillomaviruses in pathological specimens Diagn Mol Pathol 1998, 7:317-323. 10.1097/00019606-199812000-00005 10207670
4. Vernon SD Unger ER Williams D Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture J Clin Microbiol 2000, 38:651-655. 86168 10655362
5. Johnson T Bryder K Corbet S Fomsgaard A Routine genotyping of human papillomavirus samples in Denmark APMIS 2003, 111:398-404. 10.1034/ j.1600-0463.2003.t01-1-1110204.x 12752219
6. Speich N Schmitt C Bollmann R Bollmann M Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: Genotype spectrum of patients from the west German area J Med Microbiol 2004, 53:125-128. 10.1099/jmm.0.05447-0 14729933
7. Kosel S Burggraf S Mommsen J Engelhardt W Olgemoller B Type-specific detection of human papillomaviruses in a routine laboratory setting - improved sensitivity and specificity of PCR and sequence analysis compared to direct hybridisation Clin Chem Lab Med 2003, 41:787-791. 10.1515/CCLM.2003.119 12880142
8. Asato T Maehama T Nagai Y Kanazawa K Uezato H Kariya K A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping J Infect Dis 2004, 189:1829-1832. 10.1086/382896 15122519
9. Centers for Disease Control and Prevention Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections MMWR Morb Mortal Wkly Rep 2002, 51(RR15):1-27.
10. Altman DG Bland JM Diagnostic tests 2: Predictive values BMJ 1994, 309:102. 2540558 8038641
11. Culler EE Caliendo AM Nolte FS Reproducibility of positive test results in the BDProbeTec ET system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae J Clin Microbiol 2003, 41:3911-3914. 179826 12904416 10.1128/JCM.41.8.3911-3914.2003
12. Milford (city (balance)), Connecticut State & County QuickFacts U.S. Census Bureau http://www.census.gov
13. Hovey D State must do more to prevent cervical cancer http://www.housegop.ct.gov/ %5Cpressrel%5CHoveyD112%5C2007%5C20070116_HoveyD112_01.pdf
14. Kurman RJ Henson DE Herbst AL Noller KL Schiffman MH Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop JAMA 1994, 271:1866-1869. 10.1001/jama.271.23.1866 8196145
15. Lee SH Vigliotti VS Vigliotti JS Pappu S Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories Infect Agent Cancer 2007, 2:11. 1894957 17550589 10.1186/1750-9378-2-11
16. Lee SH Vigliotti VS Pappu S DNA Sequencing Validation of Chlamydia trachomatis and Neisseria gonorrhoeae Nucleic Acid Tests Am J Clin Pathol 2008, 129:852-859. 10.1309/Y2202RVCGRWW1RWB 18480000
17. Lee SH Vigliotti VS Pappu S Human papillomavirus (HPV) infection among women in a representative rural and suburban population of the United States Inter J Gyn Ob 2009.
18. Gharizadeh B Oggionni M Zheng B Akom E Pourmand N Ahmadian A Wallin KL Nyren P Type-specific multiple sequencing primers: A novel strategy for reliable and rapid genotyping of human papillomaviruses by pyrosequencing technology J Mol Diagn 2005, 7:198-205. 1867525 15858143
19. Monsonego J Pollini G Evrard MJ Sednaoui P Monfort L Quinzat D Dachez R Syrjänen K Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear Int J STD AIDS 2008, 19(6):385-392. 18595876
20. Klug SJ Molijn A Schopp B Holz B Iftner A Quint W J F Snijders P Petry KU Krüger Kjaer S Munk C Iftner T Comparison of the performance of different HPV genotyping methods for detecting genital HPV types J Med Virol 2008, 80:1264-1274. 10.1002/jmv.21191 18461626
21. Wallin KL Wiklund F Angström T Bergman F Stendahl U Wadell G Hallmans G Dillner J Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer N Engl J Med 1999, 341:1633-1638. 10.1056/NEJM199911253412201 10572150
22. Kjaer SK Brule van den AJ Paull G Svare EI Sherman ME Thomsen BL Suntum M Bock JE Poll PA Meijers CJ Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: Population based prospective follow up study BMJ 2002, 325:572-576. 124551 12228133 10.1136/ bmj.325.7364.572
23. Cuschieri KS Cubie HA Whitley MW Gilkison G Arends MJ Graham C McGoogan E Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study J Clin Pathol 2005, 58:946-950. 1770812 16126875 10.1136/jcp.2004.022863
24. Brummer O Hollwitz B Bohmer G Kuhnle H Petry KU Human papillomavirus-type persistence patterns predict the clinical outcome of cervical intraepithelial neoplasia Gynecol Oncol 2006, 102:517-522. 10.1016/j.ygyno.2006.01.020 16483642
25. Schmitt M Bravo IG Snijders PJ Gissmann L Pawlita M Waterboer T Bead-based multiplex genotyping of human papillomaviruses J Clin Microbiol 2006, 44:504-512. 1392679 16455905 10.1128/ JCM.44.2.504-512.2006
26. Schiffman M Wheeler CM Dasgupta A Solomon D Castle PE The ALTS Group A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal Papanicolaou smears Am J Clin Pathol 2005, 124:722-732. 10.1309/E067X0L1U3CY37NW 16203281
27. Stout NK Goldhaber-Fiebert JD Ortendahl JD Goldie SJ Trade-offs in cervical cancer prevention: Balancing benefits and risks Arch Intern Med 2008, 168:1881-1889. 10.1001/archinte.168.17.1881 18809815
28. Paulo M Borges AB Duarte G Quintana SM Montes MB Toloi MR The environmental cofactors in carcinogenesis in high risk HPV/HIV-positive women Braz J Infect Dis 2007, 11:189-195. 10.1590/ S1413-86702007000200003 17625758
29. Naucler P Ryd W Törnberg S Strand A Wadell G Elfgren K Rådberg T Strander B Forslund O Hansson BG Hagmar B Johansson B Rylander E Dillner J Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening J Natl Cancer Inst 2009, 101:88-99. 10.1093/jnci/djn444 19141778
30. Ripa T Nilsson P A variant of Chlamydia trachomatis with deletion in cryptic plasmid: Implications for use of PCR diagnostic tests Euro Surveill 2006, 11:E061109. 17213548
31. Ripa T Nilsson PA A Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests Sex Transm Dis 2007, 34:255-256. 17483723
32. Whiley DM LeCornec GM Mackay IM Siebert DJ Sloots TP A real-time PCR assay for the detection of Neisseria gonorrhoeae by LightCycler Diagn Microbiol Infect Dis 2002, 42:85-89. 10.1016/S0732-8893(01)00326-1 11858902
33. Tabrizi SN Chen S Cohenford MA Lentrichia BB Coffman E Shultz T Tapsall JW Garland SM Evaluation of real time polymerase chain reaction assays for confirmation of Neisseria gonorrhoeae in clinical samples tested positive in the Roche Cobas Amplicor assay Sex Transm 2004, 80:68-71. 10.1136/sti.2003.006239
34. Tabrizi SN Chen S Tapsall J Garland SM Evaluation of opa-based real-time PCR for detection of Neisseria gonorrhoeae Sex Transm Dis 2005, 32:199-202. 10.1097/01.olq.0000154495.24519.bf 15729160
35. Geraats-Peters CW Brouwers M Schneeberger PM Zanden van der AG Bruisten SM Weers-Pothoff G Boel CH Brule van den AJ Harmsen HG Hermans MH Specific and sensitive detection of Neisseria gonorrhoeae in clinical specimens by real-time PCR J Clin Microbiol 2005, 43:5653-5659. 1287782 16272500 10.1128/JCM.43.11.5653-5659.2005
36. Mangold KA Regner M Tajuddin M Tajuddin AM Jennings L Du H Kaul KL Neisseria species identification assay for the confirmation of Neisseria gonorrhoeae-positive results of the COBAS Amplicor PCR J Clin Microbiol 2007, 45:1403-1409. 1865884 17360838 10.1128/JCM.00834-06
37. Whiley DM Buda PJ Bayliss J Cover L Bates J Sloots TP A new confirmatory Neisseria gonorrhoeae real-time PCR assay targeting the porA pseudogene Eur J Clin Microbiol Infect Dis 2004, 23(9):705-710. 10.1007/ s10096-004-1170-0 15248092
38. Whiley DM Tapsall JW Sloots TP Nucleic acid amplification testing for Neisseria gonorrhoeae: An ongoing challenge J Mol Diagn 2006, 8:3-15. Review 1871692 16436629 10.2353/jmoldx.2006.050045
39. Gibbs CP Meyer TF Genome plasticity in Neisseria gonorrhoeae FEMS Microbiol Lett 1996, 145:173-179. 10.1111/j.1574-6968.1996.tb08574.x 8961554
40. Linz B Schenker M Zhu P Achtman M Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis Mol Microbiol 2000, 36:1049-1058. 10.1046/j.1365-2958.2000.01932.x 10844690
41. Martin IM Ison CA Detection of mixed infection of Neisseria gonorrhoeae Sex Transm Infect 2003, 79:56-58. 1744612 12576616 10.1136/sti.79.1.56
42. Lum G Freeman K Nguyen NL Limnios EA Tabrizi SN Carter I Chambers IW Whiley DM Sloots TP Garland SM Tapsall JW A cluster of culture positive gonococcal infections but with false negative cppB gene based PCR Sex Transm Infect 2005, 81:400-402. 1745040 16199739 10.1136/sti.2004.013805
43. Bruisten SM Noordhoek GT Brule van den AJ Duim B Boel CH El-Faouzi K du Maine R Mulder S Luijt D Schirm J Multicenter validation of the cppB gene as a PCR target for detection of Neisseria gonorrhoeae J Clin Microbiol 2004, 42:4332-4334. 516305 15365038 10.1128/ JCM.42.9.4332-4334.2004